BPC-157 / TB-500 Mix
Peptiva
BPC-157 / TB-500 Mix
ISKLJUČIVO ZA IN VITRO LABORATORIJSKA ISTRAŽIVANJA.
Nije namijenjen osobnoj, kliničkoj, dijagnostičkoj ili veterinarskoj primjeni niti primjeni na ljudima ili životinjama.
Description and specifications
What is the BPC-157 / TB-500 Mix?
The mixture combines BPC-157 and a material labeled as TB-500. It is intended for researching the responses of individual and combined components in appropriate laboratory models. Co-packaging does not prove synergy.
Mechanism and Scientific Context
BPC-157 is studied in preclinical models of vascular, tissue, and inflammatory signaling. For TB-500, the sequence and identity must first be confirmed; findings for full thymosin beta-4 cannot be automatically attributed to another material of that name. Combined experiments can investigate whether responses are additive, independent, or interrelated.
Main Research Areas
- comparison of individual and combined peptide responses
- cellular migration, angiogenesis, and microcirculation
- models of connective, muscle, and gastrointestinal tissue
- inflammatory signaling and extracellular matrix
How to interpret research data?
Data on individual components do not confirm the properties of the finished mixture. It is necessary to distinguish between raw material analyses and final batch analyses and to investigate interactions, stability, and composition under appropriate controlled conditions.
Available Peptiva variants
- 5 mg + 5 mg · Lyophilized vial
- 5 mg + 5 mg · Research dispenser
- 10 mg + 10 mg · Lyophilized vial
- 10 mg + 10 mg · Research dispenser
Select an available variant and check its name, total content, and price. The photo is not a substitute for the declaration of the selected variant.
Package format and content
Research dispenser: the variant contains a fully pre-filled dispenser with the selected content, not just a separate replacement cartridge. The quantity listed with the variant refers to the total declared content, not the amount per individual use.
Lyophilized vial: the variant contains lyophilized material in a vial, without a dispenser. This description does not refer to bacteriostatic water or a separate empty container.
Storage and handling conditions depend on the specific formulation and batch declaration. The packaging format does not confirm sterility, dosing precision, stability, or suitability for human or animal use.
Important limitations
Combining molecules does not prove synergy or clinical benefit. Any conclusions must be based on a controlled experimental design.
Batch documentation
For inquiries about available COA documentation, please contact peptivacomhr@gmail.com with the product name and LOT number if known. The availability and scope of analyses are checked for the specific batch. COA does not, by itself, prove sterility or suitability for human or animal use.
Purpose and limitations: The product is intended exclusively for laboratory research. It is not intended for human or animal use, diagnosis, treatment, mitigation, or prevention of diseases. The description is not medical advice. The research-use-only label and packaging name do not, by themselves, determine the regulatory status of the product or prove its safety or sterility.
COA on request
To enquire about a certificate of analysis (COA), send the material name, requested variant and LOT / batch number if available. Documents are not published on this page.
Request a COA by emailThe button opens your email app with a prepared enquiry. You send the message yourself. peptivacomhr@gmail.com
A COA applies to a specific batch. A purity result alone does not establish sterility, absence of endotoxins or safety for use in humans or animals.